Menu
MENU

Inspired to
change
tomorrow

This website is intended for US residents only.

We’re committed to bringing effective and reliable medicines to patients. Our research helps us better understand disease. It allows us to test and develop new medicines. It lets us teach people more about their disease and treatment options.

We are dedicated to improving the lives of patients through developing and providing access to new treatments.

Research and Development at Astellas

Our research focuses on serious diseases.

Some areas we are working on are:

  • oncology (cancer)
  • vaccines
  • acute kidney injury
  • psychosis (mental disorders)
  • pain (from nerve stimulation)
  • pediatrics (childhood diseases)
  • neuromuscular diseases (muscle function impairment)
  • autoimmune diseases (caused by the immune system)

When we create new medicines to help patients, we put science and innovation first. We work with some of the world’s top institutes, who share our vision.

New Areas of Research

By exploring new treatment areas, we can help even more people.

Right now, we are:

  • Expanding to muscular dystrophy (muscle disease) and ophthalmology (eye disease)
  • Working with other public and private organizations to combine our strengths and speed up development of potential new medicines
  • Testing new scientific approaches like regenerative medicines (repairing or replacing injured tissue) and gene therapies (using genes to treat or prevent disease)

This will help us create new treatments that could change medical care. It will help us make a difference for patients. Most importantly, it will help us inspire hope in those who need it most.

Select Astellas Clinical Trials Seeking Participants

This section will help you find trials that may be right for you.

Learn more about them below:

ACUTE MYELOID LEUKEMIA
LACEWING NCT02752035 Clinical Trial

A study of Gilteritinib (ASP2215) in adults with FLT3 mutation positive newly diagnosed acute myeloid leukemia (AML)

Go

ACUTE KIDNEY INJURY AFTER HEART SURGERY
NCT03941483 Clinical Trial

A study of ASP1128 (MA-0217) in subjects at risk for acute kidney injury following coronary artery bypass graft (CABG) and/or valve surgery

Go

CHRONIC TYMPANIC MEMBRANE PERFORATION
NCT04305184 Clinical Trial

A Study to Assess ASP0598 Otic Solution Following Topical Application in the Ear in Patients With Chronic Tympanic Membrane Perforation (CTMP)

Go

METASTATIC UROTHELIAL CARCINOMA
NCT03474107 Clinical Trial

A study to Evaluate Enfortumab Vedotin vs Chemotherapy in Subjects with Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

Go

GASTRIC CANCER
SPOTLIGHT Clinical Trial

A study of IMAB362 plus mFOLFOX6 in patients with Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Cancer

Go

ADVANCED SOLID TUMOR
NCT03565445 Clinical Trial

A Study of ASP1948 (Anti-NRP1), as a Single Agent and in Combination with a PD-l inhibitor (Nivolumab or pembrolizumab) in Patients with Advanced Solid Tumors

Go

Clinical Trial Categories

Listed below are some current key areas of research. To learn about other Astellas trials seeking participants, visit ClinicalTrials.gov

Leukemia/ Lymphomas
Solid Tumor Cancer
Vaccines
Acute Kidney Injury
Ophthalmology
Psychosis
  • Cognitive Impairment
  • Schizophrenia
Pain
  • Diabetic Neuropathic Pain
  • Fibromyalgia
Pediatrics
  • Infectious Disease
  • Urology
Neuromuscular Diseases
  • Duchenne muscular dystrophy
  • Amyotrophic lateral sclerosis (ALS)
  • Sarcopenia or Frailty
Autoimmune Diseases
  • Lupus
  • Rheumatoid Arthritis

Results of Astellas Clinical Studies

Astellas is committed to sharing the results of our clinical trials. This is important to help advance science and better help patients. It is also the best way to tell health care providers and patients about scientific findings relating to our medicines.

Learn about results of Astellas clinical trials

To learn more about disclosure and to read our full policy, click here.